He’s an internationally renowned neurosurgeon who rides a motorbike, plays the bagpipes, and spends three months a year doing pro bono work in developing countries. Now, South-East Queensland residents can learn more about Associate Professor Charlie Teo’s career and vision for the future of brain cancer treatment in a free community event on Friday 21 August during National Science Week.

Please join us from 8-9 October 2015 for Forces in Biology, a joint symposium of UQ's Institute for Molecular Bioscience and the Mechanobiology Institute of Singapore.

A special type of synthetic sugar could be the latest weapon in the fight against superbugs.

Protagonist Therapeutics, a spin-out company from The University of Queensland’s Institute for Molecular Bioscience (IMB), has raised $40 million to begin clinical trials of an oral drug for Inflammatory Bowel Disease.

IMB researchers will team with industry partners to develop new pharmaceuticals and solar fuels with support from the Australian Research Council

University of Queensland pain treatment researchers have discovered thousands of new peptide toxins hidden deep within the venom of just one type of Queensland cone snail.

The Australian Research Council named 15 new Australian Laureate Fellows, including three UQ researchers – the Institute for Molecular Bioscience’s Professor David Craik, the School of Chemistry and Molecular Biosciences’s Professor Philip Hugenholtz and the TC Beirne School of Law’s Professor Brad Sherman.

University of Queensland researchers have launched a global search to discover antibiotics capable of combating superbug bacteria that are resistant to current antibiotics. The Community for Open Antimicrobial Drug Discovery (CO-ADD) is a not-for-profit initiative funded by $3.1 million from the Wellcome Trust, and led by researchers at IMB.